Abstract
A series of aporphines and oxoaporphines was tested for antiplatelet and vasorelaxing
actions. (+)-N-Methylactinodaphnine, (-)-norannuradhapurine HBr, xylopine, actinodaphnine, and N-methylnandigerine showed strong inhibition of adenosine 5′-diphosphate (ADP)-induced
platelet aggregation. Boldine, (+)-N-methylactinodaphnine, (-)-norannuradhapurine HBr, xylopine, N-acetyllaurolitsine, N-methyllaurotetanine, actinodaphnine, N-methylnandigerine, O-methylbulbocapnine, and liriodenine showed strong inhibition of arachidonic acid
(AA)-induced platelet aggregation. (+)-N-Methylactinodaphnine, fissoldine HClO4, (-)-norannuradhapurine HBr, xylopine, N-methyllaurotetanine, actinodaphnine, N-methylnandigerine, O-methylbulbocapnine, and liriodenine showed strong inhibition of collagen-induced
platelet aggregation. (-)-Norannuradhapurine HBr, xylopine, N-methyllaurotetanine, and actinodaphnine showed strong inhibition of platelet-activating
factor (PAF; 1 -O-alkyl-2-acetyl-sn-glycero-3-phosphocholine)-induced platelet aggregation. (+)-N-Methylactinodaphnine, laurotetanine, N-methylactinodaphnine N-oxide, oxoglaucine, boldine, and actinodaphnine showed vasorelaxing action in rat
thoracic aorta. The results are discussed on the basis of structure-activity relationships.
Key words
Antiplatelet aggregation - vasorelaxing action - aporphines - oxoaporphines